Literature DB >> 11920266

Stem cell growth factor: in situ hybridization analysis on the gene expression, molecular characterization and in vitro proliferative activity of a recombinant preparation on primitive hematopoietic progenitor cells.

A Hiraoka1, K Yano Ki, N Kagami, K Takeshige, H Mio, H Anazawa, S Sugimoto.   

Abstract

INTRODUCTION: In situ hybridization of whole mouse fetuses and their tibias with a stem cell growth factor (SCGF) antisense probe demonstrated specific expression of SCGF mRNA around skeletal tissues, particularly in bone marrow cells, proliferating chondrocytes, the perichondrium and periosteum, but little expression in resting or hypertrophic chondrocytes.
METHODS: Recombinant human (rh) SCGF-alpha was purified from a conditioned medium of SCGF-alpha gene-transfected CHO cells. The molecular mass of rhSCGF-alpha, 45 kDa, was shifted down to 40 kDa by digestion with endo-O-glycosidase and sialidase, suggesting O-glycosylation of rhSCGF-alpha with sialic acids.
RESULTS: For human bone marrow CD34+Lin- cells, rhSCGF-alpha alone did not stimulate colony-formation, but small cluster-formation (10.3 +/- 2.5/1 x 10(3) CD34+Lin- cells). It promoted growth of erythroid and granulocyte/macrophage (GM) colonies in the primary culture with erythropoietin and GM colony-stimulating factor (CSF) or G-CSF, respectively, and further supported GM progenitor cells in a short-term liquid culture. In contrast, rhSCGF-alpha suppressed stem cell factor (SCF)-stimulated erythroid bursts, indicating some competitive interaction between SCGF and SCF. rhSCGF-alpha was synergistic with interleukin-3 and the flt3 ligand to enhance GM colony-growth, but not synergistic with those inducing ex vivo expansion of GM progenitor cells.
CONCLUSION: SCGF is selectively produced by osseous and hematopoietic stromal cells, and can mediate their proliferative activity on primitive hematopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11920266     DOI: 10.1038/sj.thj.6200118

Source DB:  PubMed          Journal:  Hematol J        ISSN: 1466-4860


  22 in total

1.  A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia.

Authors:  Collins Ouma; Christopher C Keller; Gregory C Davenport; Tom Were; Stephen Konah; Michael F Otieno; James B Hittner; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

2.  mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray.

Authors:  Orsolya Galamb; Ferenc Sipos; Elek Dinya; Sandor Spisak; Zsolt Tulassay; Bela Molnar
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

3.  Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

Authors:  A Laganà; D Perumal; D Melnekoff; B Readhead; B A Kidd; V Leshchenko; P-Y Kuo; J Keats; M DeRome; J Yesil; D Auclair; S Lonial; A Chari; H J Cho; B Barlogie; S Jagannath; J T Dudley; S Parekh
Journal:  Leukemia       Date:  2017-06-23       Impact factor: 11.528

4.  Daidzein Activates Akt Pathway to Promote the Proliferation of Female Germline Stem Cells through Upregulating Clec11a.

Authors:  Fangfang Li; Xiaopeng Hu; Ji Wu
Journal:  Stem Cell Rev Rep       Date:  2022-06-03       Impact factor: 5.739

5.  An efficient immunoassay for the B cell help function of SARS-CoV-2-specific memory CD4+ T cells.

Authors:  Asgar Ansari; Shilpa Sachan; Bimal Prasad Jit; Ashok Sharma; Poonam Coshic; Alessandro Sette; Daniela Weiskopf; Nimesh Gupta
Journal:  Cell Rep Methods       Date:  2022-05-10

6.  Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations.

Authors:  Alexandra H Mandarano; Jessica Maya; Ludovic Giloteaux; Daniel L Peterson; Marco Maynard; C Gunnar Gottschalk; Maureen R Hanson
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

7.  Suppression of a novel hematopoietic mediator in children with severe malarial anemia.

Authors:  Christopher C Keller; Collins Ouma; Yamo Ouma; Gordon A Awandare; Gregory C Davenport; Tom Were; James B Hittner; John M Vulule; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

8.  Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy.

Authors:  Luca Da Riva; Fabio Bozzi; Piera Mondellini; Francesca Miccichè; Elena Fumagalli; Elena Vaghi; Eva Tarantino; Veronica Huber; Alessandro Gronchi; Elena Tamborini; Marco A Pierotti; Silvana Pilotti; Italia Bongarzone
Journal:  J Transl Med       Date:  2011-09-23       Impact factor: 5.531

Review 9.  Severe malarial anemia: innate immunity and pathogenesis.

Authors:  Douglas J Perkins; Tom Were; Gregory C Davenport; Prakasha Kempaiah; James B Hittner; John Michael Ong'echa
Journal:  Int J Biol Sci       Date:  2011-11-02       Impact factor: 6.580

10.  Donor hematopoietic stem cells confer long-term marrow reconstitution by self-renewal divisions exceeding to that of host cells.

Authors:  Sushmita Roy; Saleem Javed; Swatantra K Jain; Subeer S Majumdar; Asok Mukhopadhyay
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.